Gonadotropin-releasing hormone signaling pathways in an experimental ovarian tumor.

Abstract

Previous results showed that GnRH signaling is altered in cells from rat luteinized ovarian tumors (tumor group) because it did not activate the phospholipase C pathway, in contrast to control ovarian cells from superovulated prepubertal rats (SPO). In the present work, alternate GnRH-induced second messengers such as phospholipase A(2) and phospholipase D activation, cAMP production, ERK1/2 phosphorylation, and the presence of G proteins were evaluated to determine GnRH mechanism of action in tumor cells. G proteins examined were present in both cell types. Buserelin, a GnRH agonist, (1, 10, and 100 ng/ml) increased phosphatidylethanol in SPO, indicating phospholipase D activation. Only 100 ng/ml buserelin induced a significant response in the tumor group. Buserelin (100 ng/ml) increased (3)H-arachidonic acid in culture media in SPO, indicating phospholipase A(2) activation; no effect was observed in the tumor group. Buserelin (100 and 1000 ng/ml) induced pertussis toxin-insensitive cAMP increases in both cell types, with similar potencies. In the tumor group, buserelin (100 ng/ml) inhibited human chorionic gonadotropin-induced cAMP and progesterone; this effect was protein kinase C (PKC) dependent (inhibited by GF109203X, a PKC inhibitor). Buserelin (100 and 1000 ng/ml) induced ERK1/2 phosphorylation in both cell kinds. Buserelin-induced ERK1/2 activation was G(i/0) independent and PKC dependent. Only in the tumor group, buserelin-induced ERK1/2 activation was cAMP dependent (abolished by SQ 22536, the adenylyl cyclase inhibitor). Furthermore, dibutyryl cAMP-induced ERK1/2 activation in the tumor group was PKC dependent (inhibited by GF109203X). In conclusion, activation of phospholipases in tumor cells does not seem to mediate GnRH effects. GnRH signaling seems to involve adenylyl cyclase activation, PKC stimulation, and ERK1/2 phosphorylation.

• Authors: Astrid Chamson-Reig, Eleonora M Sorianello, Paolo N Catalano, Marina O Fernández, Omar P Pignataro, Carlos Libertun, Victoria A R Lux-Lantos
• Journal: Endocrinology (Endocrinology) Vol. 144 Issue 7 Pg. 2957-66 (Jul 2003) ISSN: 0013-7227 [Print] United States
• PMID: 12810551 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antineoplastic Agents, Hormonal
• Carcinogens
• GTP-Binding Protein alpha Subunits
• olfactory G protein subunit alpha olf
• Gonadotropin-Releasing Hormone
• Progesterone
• Cyclic AMP
• Pertussis Toxin
• Protein Kinase C
• Mitogen-Activated Protein Kinase 1
• Mitogen-Activated Protein Kinase 3
• Mitogen-Activated Protein Kinases
• Phospholipases A
• Phospholipase D
• GTP-Binding Protein alpha Subunits, Gi-Go
• Heterotrimeric GTP-Binding Proteins
• Adenylyl Cyclases
• Tetradecanoylphorbol Acetate
• Buserelin

Topics

• Adenylyl Cyclases (metabolism)
• Animals
• Antineoplastic Agents, Hormonal (pharmacology)
• Buserelin (pharmacology)
• Carcinogens (pharmacology)
• Cyclic AMP (metabolism)
• Enzyme Activation (drug effects)
• Female
• GTP-Binding Protein alpha Subunits
• GTP-Binding Protein alpha Subunits, Gi-Go (metabolism)
• Gonadotropin-Releasing Hormone (metabolism)
• Heterotrimeric GTP-Binding Proteins (metabolism)
• Luteoma (metabolism)
• Mitogen-Activated Protein Kinase 1 (metabolism)
• Mitogen-Activated Protein Kinase 3
• Mitogen-Activated Protein Kinases (metabolism)
• Ovarian Neoplasms (metabolism)
• Pertussis Toxin (pharmacology)
• Phospholipase D (metabolism)
• Phospholipases A (metabolism)
• Phosphorylation (drug effects)
• Progesterone (metabolism)
• Protein Kinase C (metabolism)
• Rats
• Rats, Sprague-Dawley
• Signal Transduction (physiology)
• Tetradecanoylphorbol Acetate (pharmacology)
• Tumor Cells, Cultured